379 related articles for article (PubMed ID: 18789071)
1. Positive direct immunofluorescence and autoantibody profiles in psoriasis patients.
Janjumratsang P; Phainupong D; Chanjanakijskul S; Roongphibulsopit P
J Dermatol; 2008 Aug; 35(8):508-13. PubMed ID: 18789071
[TBL] [Abstract][Full Text] [Related]
2. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
4. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
Almogren A
Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
[TBL] [Abstract][Full Text] [Related]
5. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
Magro CM; Dyrsen ME
J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
[TBL] [Abstract][Full Text] [Related]
6. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
7. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
8. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
9. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
11. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
12. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of antibodies to double-stranded DNA by the Crithidia luciliae immunofluorescence test.
Nilsson E; Biberfeld G
J Clin Lab Immunol; 1980 May; 3(3):197-201. PubMed ID: 6999158
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
[TBL] [Abstract][Full Text] [Related]
15. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcón GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae SC; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
Lupus; 2011 Mar; 20(3):250-5. PubMed ID: 21362750
[TBL] [Abstract][Full Text] [Related]
17. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
18. [The lupus band test in the diagnosis of systemic lupus erythematosus: its decisive usefulness in cases negative for anti-ds-DNA and anti-SM].
Scarpa R; Carrela M; Casiere D; Larizza G; Del Puente A; di Girolamo C; della Valle G; Oriente P
Recenti Prog Med; 1990 Dec; 81(12):812-5. PubMed ID: 2075287
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patients.
El-Chennawi FA; Mosaad YM; Habib HM; El-Degheidi T
Immunol Invest; 2009; 38(8):839-50. PubMed ID: 19860592
[TBL] [Abstract][Full Text] [Related]
20. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]